18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Two-stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling to MNK.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BDNF signaling contributes to protein-synthesis-dependent synaptic plasticity, but the dynamics of TrkB signaling and mechanisms of translation have not been defined. Here, we show that long-term potentiation (LTP) consolidation in the dentate gyrus of live rodents requires sustained (hours) BDNF-TrkB signaling. Surprisingly, this sustained activation maintains an otherwise labile signaling pathway from TrkB to MAP-kinase-interacting kinase (MNK). MNK activity promotes eIF4F translation initiation complex formation and protein synthesis in mechanistically distinct early and late stages. In early-stage translation, MNK triggers release of the CYFIP1/FMRP repressor complex from the 5'-mRNA cap. In late-stage translation, MNK regulates the canonical translational repressor 4E-BP2 in a synapse-compartment-specific manner. This late stage is coupled to MNK-dependent enhanced dendritic mRNA translation. We conclude that LTP consolidation in the dentate gyrus is mediated by sustained BDNF signaling to MNK and MNK-dependent regulation of translation in two functionally and mechanistically distinct stages.

          Related collections

          Author and article information

          Journal
          Cell Rep
          Cell reports
          2211-1247
          Nov 20 2014
          : 9
          : 4
          Affiliations
          [1 ] Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; KG Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, 5009 Bergen, Norway.
          [2 ] Centre for Biological Sciences, Life Sciences Building, Highfield Campus, University of Southampton, Southampton SO17 1BJ, UK.
          [3 ] Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
          [4 ] CIR Department, Faculty of Medicine, University Campus Bio-Medico, 00128 Rome, Italy.
          [5 ] Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
          [6 ] Department of Biochemistry, Osaka University of Pharmaceutical Sciences, Osaka 569-1094, Japan.
          [7 ] Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy; VIB Center for the Biology of Disease, 3000 Leuven, Belgium; Center for Human Genetics and Leuven Institute for Neuroscience and Disease (LIND), KU Leuven, 3000 Leuven, Belgium.
          [8 ] Centre for Biological Sciences, Life Sciences Building, Highfield Campus, University of Southampton, Southampton SO17 1BJ, UK; South Australian Health and Medical Research Institute, and School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA 5000, Australia.
          [9 ] Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; KG Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, 5009 Bergen, Norway. Electronic address: clive.bramham@biomed.uib.no.
          Article
          S2211-1247(14)00870-5
          10.1016/j.celrep.2014.10.016
          25453757
          7cd3a765-e061-42fa-8957-a6ce35c0433a
          Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article